Education
About Us
Working with TipRanks
Follow Us
Capstone Therapeutics Corp (CAPS)
NASDAQ:CAPS
CAPS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.96 - $16.18
Previous CloseN/A
Volume2.10K
Average Volume (3M)3.73M
Market Cap
$6.47M
Enterprise Value$29.73M
Total Cash (Recent Filing)$773.00K
Total Debt (Recent Filing)$14.91M
Price to Earnings (P/E)―
Beta0.71
Next Earnings
Apr 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.13
Shares Outstanding5,581,205
10 Day Avg. Volume10,905,206
30 Day Avg. Volume3,728,903
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap4.59
Enterprise Value/Revenue0.69
Enterprise Value/Gross Profit3.12
Enterprise Value/Ebitda-23.17
Forecast
1Y Price Target
$1.00Price Target Upside-11.50% Downside
Rating ConsensusHold
Number of Analyst Covering0
Capstone Therapeutics News
CAPS FAQ
What was Capstone Therapeutics Corp’s price range in the past 12 months?
Capstone Therapeutics Corp lowest stock price was $0.96 and its highest was $16.18 in the past 12 months.
What is Capstone Therapeutics Corp’s market cap?
Capstone Therapeutics Corp’s market cap is $6.47M.
When is Capstone Therapeutics Corp’s upcoming earnings report date?
Capstone Therapeutics Corp’s upcoming earnings report date is Apr 07, 2026 which is in 208 days.
How were Capstone Therapeutics Corp’s earnings last quarter?
Capstone Therapeutics Corp released its earnings results on Aug 19, 2025. The company reported -$0.13 earnings per share for the quarter, missing the consensus estimate of -$0.07 by -$0.06.
Is Capstone Therapeutics Corp overvalued?
According to Wall Street analysts Capstone Therapeutics Corp’s price is currently Overvalued.
Does Capstone Therapeutics Corp pay dividends?
Capstone Therapeutics Corp does not currently pay dividends.
What is Capstone Therapeutics Corp’s EPS estimate?
Capstone Therapeutics Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Capstone Therapeutics Corp have?
Capstone Therapeutics Corp has 5,581,205 shares outstanding.
What happened to Capstone Therapeutics Corp’s price movement after its last earnings report?
Capstone Therapeutics Corp reported an EPS of -$0.13 in its last earnings report, missing expectations of -$0.07. Following the earnings report the stock price went down -4.386%.
Which hedge fund is a major shareholder of Capstone Therapeutics Corp?
Currently, no hedge funds are holding shares in CAPS
Company Description
Capstone Therapeutics Corp
Capstone Therapeutics (CAPS) is a biopharmaceutical company focused on developing innovative therapies for unmet medical needs in the fields of oncology and autoimmune diseases. The company leverages advanced technologies and a robust pipeline of drug candidates to create targeted treatments that aim to improve patient outcomes. With a commitment to research and development, CAPS is positioned at the intersection of biotechnology and healthcare, striving to deliver breakthrough solutions to challenging medical conditions.
Technical Analysis
Ownership Overview
―
Insiders
―
Mutual Funds
0.20% Other Institutional Investors
99.80% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---